Cardiac Rehabilitation After Coronary Artery Bypass Graft Surgery

Not Applicable

Completed

• Conditions: Cardiac Rehabilitation; Coronary Artery Bypass Surgery

• Registration Number: NCT06970938
• Lead Sponsor: Muhammed Onur Hanedan

Brief Summary

This study aimed to evaluate the effects of cardiac rehabilitation program after CABG surgery on quality of life, sleep quality, anxiety, depression and cardiopulmonary functions.

Detailed Description

Hypothesis 1:

H0: Cardiac rehabilitation has no effect on quality of life patients with CABG surgery.

H1: Cardiac rehabilitation has an effect on quality of life patients with CABG surgery.

Hypothesis 2:

H0: Cardiac rehabilitation has no effect on sleep quality patients with CABG surgery.

H1: Cardiac rehabilitation has an effect on sleep quality patients with CABG surgery.

Hypothesis 3:

H0: Cardiac rehabilitation has no effect on anxiety and depression patients with CABG surgery.

H1: Cardiac rehabilitation has an effect on anxiety and depression with CABG surgery.

H0: Cardiac rehabilitation has no effect on cardiopulmonary function patients with CABG surgery.

H1: Cardiac rehabilitation has an effect on cardiopulmonary function patients with CABG surgery.

Study Timeline

• Study Start: 2025-01-01
• Primary Completion: 2025-04-29
• Study Completion: 2025-04-29
• Status Verified: 2025-05
• Study First Submitted: 2025-05-05
• Study First Submitted QC: 2025-05-12
• Last Update Submitted: 2025-05-12
• Study First Posted: 2025-05-14
• Last Update Posted: 2025-05-14

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 28

Inclusion Criteria

• Patients who had isolated CABG surgery 3 months ago, patients with EF 50% and above, patients who are eligible for the CR program, patients who agree to participate in the study, patients who are 18 years of age and above

Exclusion Criteria

• Patients who did not consent to participate in the study, patients who had emergency CABG surgery, patients who had minimally invasive CABG surgery, patients who had repeat cardiac surgery, patients with a disease that was not suitable for the CR program (e.g., stage IV heart failure, unstable angina), patients with EF < 50%, patients with a psychiatric diagnosis and patients using medications

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Evaluation of quality of life of groups	ıt ranges from 3 months to 6 months	SF-36 quality of life scale: Contains 36 items. Measurement of 8 dimensions is provided. These dimensions are: physical functioning, social functioning, role limitations due to physical problems, role limitations due to emotional problems, mental health, energy/vitality, pain and general health perception.
Evaluation of sleep quality of groups	ıt ranges 3 months to 6 months	Pittsburgh Sleep Quality Index: Contains 24 questions in total. 19 of these are self-report questions. Five questions are answered by the spouse or a roommate and are used for clinical information only. They are not included in the scoring. It has seven components. These components are subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbance, use of sleeping pills, and daytime dysfunction. Each item is scored between 0-3. A total score of 5 or higher indicates poor sleep quality.
Evaluation of depression and anxiety of groups	ıt ranges 3 months to 6 months	Beck Depression Scale: Consists of 21 questions. Each question has 4 answer options scored between 0 and 3. A total score between 0-13 indicates no depression, 14-19 indicates mild depression, 20-18 indicates moderate depression, and 29-63 indicates severe depression.; Beck Anxiety Scale: Consists of 21 questions. Questions are scored between 0-3. The minimum score on the scale is 0, the maximum score is 63. Increasing scores on the scale indicate an increase in the anxiety level.
Evaluation of cardiopulmonary functions of groups	ıt ranges 3 months to 6 months	6-minute walking test: It is applied in a 30-meter corridor in a closed environment. The distance the patient walks in six minutes, oxygen saturation, heart rate, and changes in dyspnea are recorded.; FEV1, FVC and FEV1/FVC values with respiratory function test, echo test for ejection fraction, blood test for LDL values, height and weight values for body mass index

Trial Locations

Locations (1)

Ahi Evren Göğüs Kalp ve Damar Cerrahisi Eğitim ve Araştırma Hastanesi; 🇹🇷 Trabzon, Turkey